Yoshioka M, Kumamoto Y, Hirose T, Maekawa S
Department of Urology, School of Medicine, Sapporo Medical University.
Kansenshogaku Zasshi. 1995 Feb;69(2):181-8. doi: 10.11150/kansenshogakuzasshi1970.69.181.
Using a mouse experimental UTI (urinary tract infection) model, a study was conducted to find the pathogenicity of various serovars of E. faecalis. On the basis of studies employing serovar-specific factor sera prepared with E. faecalis type strains, serovar 2, 3, 4 and 10 strains showed a high incidence of involvement in pyelonephritis: 90.3%, 85.7%, 85% and 73.3%. Serovar 1, 6 and 7 strains each showed a 63.6% incidence of involvement in pyelonephritis, indicating that they have a moderate pathogenicity. The pathogenicity of the other serovar strains was not very strong, with a low incidence of 40-59.1%. These results were thus in good agreement with the findings of the study using the mouse experimental UTI model infected with clinical isolates. Serotyping was performed of E. faecalis clinical isolates obtained from patients with pyelonephritis or urosepsis. Serovars 2 and 4 comprised 75.1% of these isolates. It was surmised that E. faecalis serovars 2 and 4 tend to have strong pathogenicity. Thus, there were quite a few differences in pathogenicity of E. faecalis according to each kind of serovar.
利用小鼠实验性尿路感染模型,开展了一项研究以探究粪肠球菌不同血清型的致病性。基于使用由粪肠球菌标准菌株制备的血清型特异性因子血清所进行的研究,血清型2、3、4和10的菌株在肾盂肾炎中的感染率较高:分别为90.3%、85.7%、85%和73.3%。血清型1、6和7的菌株在肾盂肾炎中的感染率均为63.6%,表明它们具有中等致病性。其他血清型菌株的致病性不是很强,感染率较低,为40 - 59.1%。因此,这些结果与使用感染临床分离株的小鼠实验性尿路感染模型的研究结果高度一致。对从肾盂肾炎或脓毒症患者中分离得到的粪肠球菌临床分离株进行了血清分型。这些分离株中血清型2和4占75.1%。据推测,粪肠球菌血清型2和4往往具有较强的致病性。因此,粪肠球菌的致病性因血清型不同而存在相当大的差异。